157 related articles for article (PubMed ID: 16261451)
1. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells.
Iu MF; Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
J Bone Miner Metab; 2005; 23(6):450-5. PubMed ID: 16261451
[TBL] [Abstract][Full Text] [Related]
2. Positive interaction between 17 beta-Estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone.
Rao LG; Kung Sutherland MS; Muzaffar SA; Wylie JN; McBroom RJ; Murray TM
Osteoporos Int; 1996; 6(2):111-9. PubMed ID: 8704348
[TBL] [Abstract][Full Text] [Related]
3. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5.
Nasu M; Sugimoto T; Kaji H; Chihara K
J Endocrinol; 2000 Nov; 167(2):305-13. PubMed ID: 11054645
[TBL] [Abstract][Full Text] [Related]
4. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
Rao LG; Murray TM; Wylie JN; McBroom RJ; Sutherland MK
J Endocrinol Invest; 2005 Nov; 28(10):919-27. PubMed ID: 16419495
[TBL] [Abstract][Full Text] [Related]
5. 17 beta-estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Sutherland MS; Murray TM
Endocrinology; 1994 Feb; 134(2):614-20. PubMed ID: 8299560
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.
Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G
Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone suppresses Smad3 pathway in osteoblastic cells.
Iu MF; Kaji H; Sowa H; Naito J; Sugimoto T; Chihara K
J Endocrinol; 2005 Apr; 185(1):131-8. PubMed ID: 15817834
[TBL] [Abstract][Full Text] [Related]
8. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation.
Kanatani M; Sugimoto T; Takahashi Y; Kaji H; Kitazawa R; Chihara K
J Bone Miner Res; 1998 May; 13(5):854-62. PubMed ID: 9610750
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM
Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
[TBL] [Abstract][Full Text] [Related]
10. Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Kudo Y; Iwashita M; Itatsu S; Iguchi T; Takeda Y
J Endocrinol; 1996 Aug; 150(2):223-9. PubMed ID: 8869589
[TBL] [Abstract][Full Text] [Related]
11. Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: zinc modulation of insulin-like growth factor-I's effect.
Yamaguchi M; Fukagawa M
Calcif Tissue Int; 2005 Jan; 76(1):32-8. PubMed ID: 15477998
[TBL] [Abstract][Full Text] [Related]
12. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
13. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones.
Ernst M; Heath JK; Rodan GA
Endocrinology; 1989 Aug; 125(2):825-33. PubMed ID: 2752978
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone.
Sutherland MS; Rao LG; Muzaffar SA; Wylie JN; Wong MM; McBroom RJ; Murray TM
Osteoporos Int; 1995; 5(5):335-43. PubMed ID: 8800783
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.
Sutherland MK; Hui DU; Rao LG; Wylie JN; Murray TM
Bone; 1996 Apr; 18(4):361-9. PubMed ID: 8726395
[TBL] [Abstract][Full Text] [Related]
18. Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells.
Christensen MH; Fenne IS; Flågeng MH; Almås B; Lien EA; Mellgren G
Biochem Biophys Res Commun; 2014 Jul; 450(1):360-5. PubMed ID: 24944021
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
